Global Intrauterine Devices Market

Global Intrauterine Devices Market Size, Share, Growth Analysis, By Type(Nonhormonal, copper-containing IUDs and hormonal), By Age(15–24 years, 25–34 years), By End-user(Hospitals, community health centers) - Industry Forecast 2024-2031

Report ID: SQMIG35A2678 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 92 | Figures: 76

Global Intrauterine Devices Market News

  • In June 2021, Sebela Pharmaceuticals Inc. partnered with PRA Health Sciences to conduct a phase III clinical trial for LevoCept, a long-acting reversible intrauterine system. The trial aims to evaluate the contraceptive efficacy, safety, and tolerability of LevoCept and is expected to be completed by June 2027.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Intrauterine Devices Market size was valued at USD 3.0 billion in 2021 and is poised to grow from USD 3.12 billion in 2022 to USD 4.20 billion by 2030, at a CAGR of 3.8% during the forecast period (2023-2030).

Given the importance of accessibility and affordability in the contraceptive market, some players adopt competitive pricing strategies. They may offer discounted or subsidized IUDs to make them more accessible to a broader population, especially in developing countries. Effective marketing and awareness campaigns are essential to educate healthcare providers and potential users about the benefits of IUDs. Companies invest in promoting their products through digital and traditional marketing channels, attending medical conferences, and conducting educational workshops. 'Actavis (Ireland)', 'Bayer (Germany)', 'Teva Pharmaceuticals (Israel)', 'Allergan (Ireland)', 'Eurogine (Spain)', 'OCON Medical (Israel)', 'Pregna (India)', 'HLL Lifecare (India)', 'HRA Pharma (France)', 'ANI Pharmaceuticals (United States)', 'Besins HealthCare (Belgium)', 'SMB (India)', 'Medicines360 (United States)', 'Medisafe Distribution (France)', 'MonaLisa N.V. (Belgium)', 'Merck & Co., Inc. (United States)', 'Pfizer Inc. (United States)', 'Trimedic Supply Network Ltd. (United Kingdom)', 'Melbea AG (Switzerland)', 'Medisafe UK Ltd. (United Kingdom)'

The growing awareness about the importance of family planning and the need for effective contraception methods has been a major driver for the intrauterine devices market . As individuals and healthcare providers recognize the benefits of long-term birth control options, the demand for IUDs has increased.

The demand for Intrauterine Devices (IUDs) is being positively influenced by the increasing prevalence of unplanned and unwanted pregnancies worldwide. Furthermore, hormonal IUDs are gaining recognition for their potential to alleviate severe cramps, heavy periods, and anemia in individuals. Efforts undertaken by health agencies and non-profit organizations in various countries to raise awareness about family planning, the benefits of birth control methods, and the health risks associated with unintended pregnancies are also contributing to the market's growth. Additionally, IUDs are becoming increasingly popular among nulliparous women and adolescents who have never given birth, as these devices have a significantly lower risk of ectopic pregnancy and adverse birth outcomes, such as breast and reproductive cancers.

North America represents the largest share of the intrauterine devices market. This region is known for its advanced healthcare infrastructure, high awareness about reproductive health, and widespread availability of contraceptive options. The demand for IUDs in North America is driven by a combination of factors, including a growing trend towards planned delayed pregnancies, increasing focus on women's reproductive rights, and a strong emphasis on family planning. Additionally, the region benefits from favorable government policies and initiatives that promote access to sexual and reproductive health services. With a well-established market and a population that values effective and long-term contraceptive solutions, North America continues to drive the growth of the intrauterine devices market .

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global Central Nervous System Biomarkers Market
Buy Now GET FREE SAMPLE
Endoscopy Procedures Market
Buy Now GET FREE SAMPLE
Global Pain Management Devices Market
Buy Now GET FREE SAMPLE
Super-resolution Microscopes Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Intrauterine Devices Market

Product ID: SQMIG35A2678

$5,300
BUY NOW GET FREE SAMPLE